FindTrial
Sign In

ââ?¬Å?A trial comparing the duration of second trimester abortion using two different doses of the same drug.ââ?¬?

"A randomized control trial in second trimester termination of pregnancy with two different regimes"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045721
Enrollment
48
Registered
2022-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Mifepristone: Mifepristone as two doses 200mcg once daily for two days Control Intervention1: MIFEPRISTONE: Mifepristone as a single dose 200mcg per oral STAT

Sponsors

Amrita Vishwa Vidyapeetham
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who will be admitted and treated for second -trimester abortions, induced abortions between 12 weeks to 20 weeks of gestation

Exclusion criteria

Exclusion criteria: Patients having miscarriages before 12 weeks of gestation. �Patient who delivered or terminated after 20 weeks 1 day.

Design outcomes

Primary

MeasureTime frame
Comparison of Induction to expulsion interval in second trimester based on induction regimes.Timepoint: From the time of drug administration to expulsion ( Within 24-72 hours )—

Secondary

MeasureTime frame
En-Sac expulsion of products Need for evacuation Duration of hospital stay Pain scale assessment Patient satisfactionTimepoint: patient admission to discharge—

Countries

India

Contacts

Public ContactDrVaishnavi Rajaraman

Amrita Institute of Medical sciences, Cochin

drsudhakishore@gmail.com9388467844

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026